Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Levent Eralp

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Oncology|January 11, 2008
A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomasMert Basaran, E Sevil Bavbek, Sezer Saglam, et al.
In Vivo (Athens, Greece)|May 13, 2014
Survival and prognostic factors in adult patients with recurrent or refractory ewing sarcoma family tumours: a 13-years retrospective study in TurkeyIbrahim Yildiz, Fatma Sen, Meltem Ekenel, et al.
Growth Factors (Chur, Switzerland)|September 25, 2007
The effect of transforming growth factor beta1 (TGF-beta1) on the regenerate bone in distraction osteogenesisKorhan Ozkan, Levent Eralp, Mehmet Kocaoglu, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|May 27, 2026
Preoperative radiotherapy negatively affects early hypertrophy but has no effect on graft survival and union in patients treated with vascularized fibular grafts for bone tumorsSerkan Bayram, İsmail Tarık Atasoy, Ahmet Salduz, et al.
Acta Orthopaedica Et Traumatologica Turcica|September 19, 2007
[Survival analysis and the effects of prognostic factors in patients treated for osteosarcoma]Harzem Ozger, Levent Eralp, Ata Can Atalar, et al.
The Bone & Joint Journal|May 1, 2024
Controversies in orthopaedic oncologyLee M Jeys, Joachim Thorkildsen, Vineet Kurisunkal, et al.
The Bone & Joint Journal|January 31, 2025
Identifying consensus and areas for future research in chondrosarcoma : a report from the Birmingham Orthopaedic Oncology MeetingLee M Jeys, Guy V Morris, Vineet J Kurisunkal, et al.
The Bone & Joint Journal|November 30, 2025
A modified Delphi consensus on periprosthetic infection in orthopaedic oncology : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM)Lee Jeys, Eduardo Botello, Richard A Boyle, et al.
Bone & Joint Open|November 19, 2025
What is debridement, antibiotics, and implant retention in orthopaedic oncology? : a global cross-sectional survey of surgeons' practices and opinionsZeeshan Khan, Zainab Aqeel Khan, Tomas Zamora, et al.
The Bone & Joint Journal|June 9, 2026
A modified Delphi consensus on tenosynovial giant cell tumour and giant cell tumour of bone : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM)Lee M Jeys, Eduardo Botello, Richard Boyle, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Oncology|January 11, 2008
A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomasMert Basaran, E Sevil Bavbek, Sezer Saglam, et al.
In Vivo (Athens, Greece)|May 13, 2014
Survival and prognostic factors in adult patients with recurrent or refractory ewing sarcoma family tumours: a 13-years retrospective study in TurkeyIbrahim Yildiz, Fatma Sen, Meltem Ekenel, et al.
Growth Factors (Chur, Switzerland)|September 25, 2007
The effect of transforming growth factor beta1 (TGF-beta1) on the regenerate bone in distraction osteogenesisKorhan Ozkan, Levent Eralp, Mehmet Kocaoglu, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|May 27, 2026
Preoperative radiotherapy negatively affects early hypertrophy but has no effect on graft survival and union in patients treated with vascularized fibular grafts for bone tumorsSerkan Bayram, İsmail Tarık Atasoy, Ahmet Salduz, et al.
Acta Orthopaedica Et Traumatologica Turcica|September 19, 2007
[Survival analysis and the effects of prognostic factors in patients treated for osteosarcoma]Harzem Ozger, Levent Eralp, Ata Can Atalar, et al.
The Bone & Joint Journal|May 1, 2024
Controversies in orthopaedic oncologyLee M Jeys, Joachim Thorkildsen, Vineet Kurisunkal, et al.
The Bone & Joint Journal|January 31, 2025
Identifying consensus and areas for future research in chondrosarcoma : a report from the Birmingham Orthopaedic Oncology MeetingLee M Jeys, Guy V Morris, Vineet J Kurisunkal, et al.
The Bone & Joint Journal|November 30, 2025
A modified Delphi consensus on periprosthetic infection in orthopaedic oncology : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM)Lee Jeys, Eduardo Botello, Richard A Boyle, et al.
Bone & Joint Open|November 19, 2025
What is debridement, antibiotics, and implant retention in orthopaedic oncology? : a global cross-sectional survey of surgeons' practices and opinionsZeeshan Khan, Zainab Aqeel Khan, Tomas Zamora, et al.
The Bone & Joint Journal|June 9, 2026
A modified Delphi consensus on tenosynovial giant cell tumour and giant cell tumour of bone : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM)Lee M Jeys, Eduardo Botello, Richard Boyle, et al.
Pageof 10